Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-09

An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy

Yuefeng Yang, Weidong Xu, Di Peng [...]

Human Gene Therapy

Retricted access

Research article

First published 2014-2

Newer developments in the immunotherapy of malignant melanoma

Benjamin Maslin, Doru T Alexandrescu, Thomas E Ichim [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

Uday N. Shivaji, Louisa Jeffery, Xianyong Gui [...]

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2018

Clinical assessment of immune-related adverse events

Aaron Sosa, Esther Lopez Cadena, Cristina Simon Olive [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)

Young Kwang Chae, Megan Othus, Sandip Pravin Patel [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer

Can Chen, Minjun Chen, Yuju Bai [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2021

Prevalence,therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis

Sophia H. Verspohl, Tobias Holderried, Charlotte Behning [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2013-11

Ipilimumab in the Treatment of Metastatic Melanoma: A Summary of Recent Studies

Paolo A Ascierto

Tumori Journal

Open access

Research article

First published 2024

High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome

Nithya Krishnamurthy, Daisuke Nishizaki, Scott M. Lippman [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2003-12

CTLA-4 AT-Repeat Polymorphism Reduces the Inhibitory Function of CTLA-4 in Graves' Disease

Masaki Takara, Tsuyoshi Kouki, Leslie J. DeGroot

Thyroid®

Search results